反応式
[CH3:1][O:2][C:3]1[N:8]=[C:7]([O:9][CH3:10])[C:6](B(O)O)=[CH:5][N:4]=1.[F:14][C:15]1[C:20](Br)=[CH:19][C:18]([CH3:22])=[CH:17][N:16]=1.C([O-])([O-])=O.[Na+].[Na+].C1C=CC(P(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>C(O)CC.CC([O-])=O.CC([O-])=O.[Pd+2]>[F:14][C:15]1[C:20]([C:6]2[C:7]([O:9][CH3:10])=[N:8][C:3]([O:2][CH3:1])=[N:4][CH:5]=2)=[CH:19][C:18]([CH3:22])=[CH:17][N:16]=1参加物
7
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
2,4-Dimethoxy-pyrimidine-5-boronic acid (842 mg, 4.60 mmol) was dissolved in degassed n-PrOH (55 ml) and then 2-fluoro-3-bromo-5-methylpyridine (800 mg, 4.21 mmol), Na2CO3 (1.46 g, 13.77 mmol), PPh3 (348 mg, 1.33 mmol) and Pd(OAc)2 (101 mg, 0.45 mmol) were added. The suspension was stirred at reflux for 2 hours. After cooling, the solvent was evaporated under vacuum and the crude was partitioned between water and ethyl acetate. The organic phase was dried (Na2SO4) and evaporated. The residue was triturated with Et2O to give 350 mg of the title compound as a gray powder (31% yield).
後処理
- temperatureat reflux for 2 hours
- temperatureAfter cooling
- customthe solvent was evaporated under vacuum
- customthe crude was partitioned between water and ethyl acetate
- dry with materialThe organic phase was dried (Na2SO4)
- customevaporated
- customThe residue was triturated with Et2O
出典と根拠
- ORDレコード
- ord-12f4a5822159455fbcc84489de49ee47
- 出典データセット
- uspto-grants-2010_06
- 特許番号
- US07727988B2
関連ノート
読み込み中…